| DISEASE |
ISOLATION OF THE PATHOGEN |
SEROTYPE ASSOCIATION |
INCREASE IN THE TITER OR QUANTITY
RECOVERED |
DETECTION OF TOXINS OR OTHER
CRITERIA |
|
Gastroenteritis caused by Bacillus cereus
|
|
The same serotype of B. cereus in stool samples of the
majority of patients, but not from the controls; or in patients and
the epidemiologically implicated food
|
Isolation of >105 cells of B. cereus per gm
of epidemiologically incriminated food.
|
Detection of the enterotoxin
|
|
Brucellosis
|
Brucella spp. in the blood of the patients or in the
epidemiologically implicated food
|
|
Quadruple increase in the agglutination titer for blood samples
taken during acute phase and 3-6 weeks after the onset of the
disease.
|
|
|
Campylobacteri-osis
|
Campylobacter jejuni in stool of almost all patients or
in epidemiologically implicated food
|
The same serotypes in patients and in the implicated food found
through DNA techniques
|
Quadruple or greater increase in the agglutination titer for
blood samples taken during acute phase and 2 - 4 weeks after onset
of the disease.
|
|
|
Botulism
|
Clostridium botulinum in patient’s stool or in
epidemiologically implicated food.
|
|
|
Detection of botulin in sera, feces, or food: there frequently
is a history of ingestion of home-canned foods or home-fermented
fish, roe, or meat of marine mammals.
|
|
Gastroenteritis caused by Clostridium
perfríngens
|
|
The same serotype of C. perfringens in specimens from
almost all the patients but not from the controls; or in patients
and in the food: epidemiologically implicated food.
|
Isolation of >106 cells of C.
perfringens per gm of epidemiologically implicated food. >
105 colonies of C. perfringens per gm of feces
from patients is presumptive proof
|
Evidence of toxin in feces using the appropriate techniques
|
|
Gastroenteritis caused by Escherichia coli spp
|
|
The same serotype of E. coli in almost all patients, but
not in the controls or in patients and the epidemiologically
implicated food. Isolation of E. Coli O157:H7 or shiga
(vero)toxigenic in the epidemiologically implicated food .
|
|
Detection of enterotoxin by culture in intestinal loop, suckling
mouse assay, tissue culture, or by other biological technique, or
invasion through the production of conjunctivitis in the eye of the
guinea pig or another technique.
|
|
Histamine as substance
|
|
|
Detection of levels of Histamine higher than 50 mg/100 g in the
muscles of fish
|
Suspicion arising from typical syndrome and background of having
consumed scombroid fish
|
|
Listeria Infection
|
Isolation of L. Monocytógenes in autopsy of fetal
material or fatal cases
|
Isolation of the same phage type in the same group of patients
and in epidemiologically implicated food
|
|
The virulence of the strains is checked through tests in
rabbits, and inoculation in mice and fertilized eggs.
|
|
Salmonellosis
|
Salmonella in stool or rectal swab (or urine or blood, if
there are septicemic symptoms) or in epidemiologically implicated
food
|
The same serotype of Salmonella in patients and in
epidemiologically implicated food
|
|
|
|
Shigellosis
|
Shigela spp in stool or rectal swab from patient or in
epidemiologically implicated food.
|
The same serotype of Shigella in patients and in
epidemiologically implicated food
|
|
|
|
Staphylococcal enterotoxicosis
|
Isolation of 105//g in S.aureus in the
epidemiologically implicated food
|
The same phage type in the vomit or stool of patients and in the
epidemiologically implicated food, and in skin, nose, or lesion of
food handlers
|
|
Detection of enterotoxin in epidemiologically implicated food,
through serological tests
|
|
Streptococcal sore throat or scarlet fever
|
|
The same M and T types of Group A or G streptococci in the
throat of patients and in epidemiologically implicated food
|
|
|
|
Cholera
|
|
|
Increase of the serum titer during the acute or early
convalescent phase of the disease, and drop in titer during the
last phase of convalescence in non-immunized people
|
Detection of enterotoxin by culture or filtrate in intestinal
loop, suckling mouse assay, tissue culture or other biological
technique
|
|
Diarrheal diseases caused by Vibrio cholerae O1, O139
|
Isolation of V. cholerae in the same O1 serotype in stool of
patients or in epidemiologically implicated food
|
|
|
|
|
Gastroenteritis caused by Vibrio
parahaemolyticus
|
Isolation of >105 cells of V.
parahaemolyticus in the epidemiologically implicated food
|
The same serotype of Kanagawa-positive V.
parahaemolyticus in the stool of almost all the patients
|
|
Suspected when an adult has a recent history of ingestion of raw
fish or shellfish.
|
|
Infection caused by Vibrio vulnificus
|
Isolation of V. vulnificus in blood of the patient
|
|
|
Usually the patients have a chronic disease related to the liver
or the blood. History of having recently ingested raw
shellfish.
|
|
Yersiniosis
|
Yersinia enterocolitica or Y. pseudotuberculosis
in most of patients or in epidemiologically implicated food
|
|
Quadruple or greater increase in the agglutination titer for
blood samples taken during the acute disease phase and 2-4 weeks
after onset of the disease
|
|
|
Other bacterial diseases
|
The criteria vary, depending on the clinical and laboratory
assessment of each case .
|
|
VIRAL DISEASE
|
|
Hepatitis A
|
Detection of IgM antihepatitis A virus in people who consumed
the implicated food
|
|
|
Liver tests, often with history of ingestion of raw
shellfish
|
|
Norwalk and related viral diseases (Virus with round small
structure)
|
Serological evidence of the virus. Observation through electron
microscope
|
|
Fourfold increase in antibody titer in serum in acute
convalescent phase.
|
Suspicion when the patients have a syndrome, incubation period
and duration of the disease compatible with the disease
described.
|
|
Parasitic
|
|
Cryptosporidi-osis
|
Detection of oocytes C. Parvum in stool of sick people
and in the food. Detection of advanced stage in biopsy of implied
or associated intestines
|
|
|
|
|
Cyclosporosis
|
Detection of oocytes of C. Cayetanensis in stool of
patients by microscopy and in association with the implicated food.
Evidence of oocyte sporulation in the food
|
|
|
|
|
Giardiasis
|
Evidence of G. Lambia in stool, duodenal contents or in
small intestine biopsy. Evidence of organism in the implicated
food
|
|
Evidence of antigen in patient’s stool
|
|
|
Toxoplasmosis
|
Recovery of the agent in the incriminated meat
|
|
Serological evidence of exposure
|
|
|
Trichinosis
|
Evidence of larvae in the food, evidence of cysts in muscle
tissue biopsy
|
|
Serological evidence of infection
|
Suspected patients with a typical profile including marked
eosinophilia and history of having consumed raw or undercooked pork
or wild animal meat
|
| Disease |
Detection of Toxin |
Other criteria |
|
Diarrheal shellfish poisoning
|
Detection of the toxin in the shellfish epidemiologically
involved through test with mouse
|
Evidence of large number of Dinophysis in the water from which
the epidemiologically implicated mollusks come.
|
|
Paralytic shellfish poisoning (saxitoxin)
|
Detection of saxitoxins and related toxins in the
epidemiologically implicated mollusks
|
Detection of large number of toxigenic species of
dinoflagellates in the water from which the epidemiologically
incriminated mollusks come. History of ingestion of raw shellfish
or presence of red tide in the area where the shellfish were
caught.
|
|
Ciguatera
|
Evidence of ciguatoxin in epidemiologically implicated fish
|
Typical clinical syndrome in people who have previously consumed
fish associated with ciguatera.
|
|
Puffer poisoning (tetrodotoxism)
|
Evidence of tetrodotoxin in puffer fish
|
History of ingestion of puffer fish
|
|
Poisoning caused by group of mushrooms that produces amatoxin,
phallotoxin, or gyromotrin
|
Evidence of amanitotoxin, Phallotoxin, phalloidin,
amantine in epidemiologically implicated mushrooms or in the
urine
|
History of ingestion of toxic species of mushrooms
|
|
Gastroenteritis caused by toxic mushrooms
|
Evidence of toxic chemicals in the implicated fungi or
morphological and color characteristics of the fungi
|
|
|
Poisoning by ibotenic acid or muscimol
|
Evidence of ibotenic acid or muscimol in the epidemiologically
implicated food
|
History of the patient having eaten mushrooms
|
|
Alcohol intolerance caused by ingestion of mushrooms
|
Evidence of toxic chemicals in the epidemiologically implicated
mushrooms or in the urine
|
History of having ingested species of fungi that have
disulfiram-like effect after drinking alcohol
|
|
Poisoning caused by mushrooms of the muscarine group
(muscarism)
|
Evidence of muscarine in epidemiologically implied mushrooms, or
in the urine
|
History of ingestion of toxic species of mushrooms
|
|
Poisoning by plants in general
|
Evidence of toxic substances in fruits, flowers, seeds, or bulbs
or any part of the plant
|
History of ingestion of toxic plants
|
|
Chemical substances
|
|
Monosodium glutamate
|
Evidence of high concentrations of MSG in the epidemiologically
implicated food
|
Suspected when typical syndrome occurs and high concentrations
of MSG have been added to the implicated food
|
|
Poisoning caused by heavy metals
|
Evidence of high concentration of metallic ions in the
epidemiologically implicated food or beverage
|
History of storage or preservation of very acid foods or
beverages in metal containers or tubing
|
|
Poisoning caused by other chemicals or chemical products
|
High concentrations of chemical in the epidemiologically
implicated food or beverage
|
History of use or storage of the suspected chemical near the
implicated food.
|